1. Home
  2. NICE guidance
  3. Awaiting development

Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with neurofibromatosis type 1 ID6385

Awaiting development [GID-TA11457] Expected publication date: TBC

  • Project information
  • Project documents

33516-Selumetinib-for-Plexiform-Neurofibromas-V1.0-SEP2023-NON-CONF.pdf (nihr.ac.uk)